Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

Similar articles for PubMed (Select 22989511)

1.

Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials.

Ciliberto D, Botta C, Correale P, Rossi M, Caraglia M, Tassone P, Tagliaferri P.

Eur J Cancer. 2013 Feb;49(3):593-603. doi: 10.1016/j.ejca.2012.08.019. Epub 2012 Sep 16.

PMID:
22989511
2.
3.
4.
5.

Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

Sun C, Ansari D, Andersson R, Wu DQ.

World J Gastroenterol. 2012 Sep 21;18(35):4944-58. Review.

6.
7.

[Meta-analysis on gemcitabine of fixed-dose rate infusion plus oxaliplatin as first-line therapy for advanced pancreatic cancer].

Xie DR, Liang HL, Yang Q, Guo SS, Jiang ZM.

Ai Zheng. 2007 Aug;26(8):895-9. Chinese.

PMID:
17697555
8.

Meta-analysis of phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer.

Eltawil KM, Renfrew PD, Molinari M.

HPB (Oxford). 2012 Apr;14(4):260-8. doi: 10.1111/j.1477-2574.2012.00441.x. Epub 2012 Feb 26.

9.

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

Heinemann V, Boeck S, Hinke A, Labianca R, Louvet C.

BMC Cancer. 2008 Mar 28;8:82. doi: 10.1186/1471-2407-8-82.

10.

Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis.

Gresham GK, Wells GA, Gill S, Cameron C, Jonker DJ.

BMC Cancer. 2014 Jun 27;14:471. doi: 10.1186/1471-2407-14-471. Review.

11.

Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials.

Bria E, Milella M, Gelibter A, Cuppone F, Pino MS, Ruggeri EM, Carlini P, Nisticò C, Terzoli E, Cognetti F, Giannarelli D.

Cancer. 2007 Aug 1;110(3):525-33.

12.

Comparison of gemcitabine combined with targeted agent therapy versus gemcitabine monotherapy in the management of advanced pancreatic cancer.

Li Q, Yuan Z, Yan H, Wen Z, Zhang R, Cao B.

Clin Ther. 2014 Jul 1;36(7):1054-63. doi: 10.1016/j.clinthera.2014.05.066. Epub 2014 Jun 27. Review.

PMID:
24986485
13.

WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.

Yip D, Karapetis C, Strickland A, Steer CB, Goldstein D.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002093. doi: 10.1002/14651858.CD002093.pub3. Review.

PMID:
19821291
14.

Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.

Yip D, Karapetis C, Strickland A, Steer CB, Goldstein D.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD002093. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD002093.

PMID:
16855985
15.

Polychemotherapy or gemcitabine in advanced pancreatic cancer: a meta-analysis.

Petrelli F, Coinu A, Borgonovo K, Cabiddu M, Ghilardi M, Barni S.

Dig Liver Dis. 2014 May;46(5):452-9. doi: 10.1016/j.dld.2014.01.001. Epub 2014 Feb 22.

PMID:
24565950
16.

Efficacy of gemcitabine-based chemotherapy in metastatic breast cancer: a meta-analysis of randomized controlled trials.

Li W, Wang H, Li X.

Curr Med Res Opin. 2013 Nov;29(11):1443-52. doi: 10.1185/03007995.2013.832185. Epub 2013 Sep 4.

PMID:
23927481
17.

A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer.

Gao G, Jiang J, Liang X, Zhou X, Huang R, Chu Z, Zhan Q.

Lung Cancer. 2009 Sep;65(3):339-44. doi: 10.1016/j.lungcan.2008.11.019. Epub 2009 Jan 13.

PMID:
19144444
18.
19.
20.

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma.

Hu J, Zhao G, Wang HX, Tang L, Xu YC, Ma Y, Zhang FC.

J Hematol Oncol. 2011 Mar 26;4:11. doi: 10.1186/1756-8722-4-11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk